Procyrion™ | Press Releases

Procyrion Announces Appointment of Lucas Buchanan to Board of Directors

Press Release

Lucas is an Industry veteran who brings expertise in commercialization, operations, business development, and finance to Procyrion as it continues to focus on its DRAIN-HF pivotal IDE trial and begins preparation for US commercialization of its Aortix percutaneous mechanical circulatory support (pMCS) technology.

September 9, 2024

Press Releases

Procyrion Closes $57.7 Million in Series E Financing

Press Release

Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the completion of a $57.7 million Series E funding round, including the conversion of $10.0 million of interim financing.

February 5, 2024

Press Releases

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix™ Percutaneous Mechanical Circulatory Support Technology

Press Release

Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company's IDE pivotal trial.

November 30, 2023

Press Releases

Procyrion Secures New Medicare Payment Codes Applicable to its Aortix™ Percutaneous Mechanical Circulatory Support Technology

Press Release

Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today it has successfully secured new inpatient hospital ICD-10-PCS procedure codes applicable to its Aortix™ percutaneous mechanical circulatory support (pMCS) technology.

September 7, 2023

Press Releases

Aortix™ Pump Therapy Leads to Rapid Decongestion and Improved Kidney Function in Hospitalized Patients with Heart Failure and Worsening Renal Function

Press Release

Procyrion, Inc. announced today that use of its Aortix™ percutaneous mechanical circulatory support (pMCS) device led to rapid decongestion in a pilot study of patients admitted to the hospital with acute decompensated heart failure (ADHF) and worsening renal function, which is known as cardiorenal syndrome (CRS).

March 21, 2023

Press Releases

Procyrion Announces Successful First-in-Human Cases with Aortix™ Pump to Prevent Acute Kidney Injury in Patients Undergoing Cardiac Surgery

Press Release

Procyrion announces successful first-in-human cases with Aortix™ pump to prevent acute kidney injury in patients undergoing cardiac surgery. Study adds to the growing body of data for the Aortix™ pump, which will be featured in a presentation at the Technology and Heart Failure Therapeutics conference in March.

February 22, 2023

Press Releases

Procyrion’s Aortix™ Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting

Press Release

Procyrion’s Aortix™ Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting

November 2, 2021

Press Releases

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

Press Release

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

May 25, 2021

Press Releases

Procyrion Names Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing

Press Release

Av Edidin, Ph.D., brings > 25 years of in depth experience as a global medical device leader, and will help Procyrion prepare for upcoming clinical studies of the Aortix™ system for the treatment of in-hospital cardiorenal patients.

August 6, 2019

Press Releases

Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System

Press Release

• Resting the heart while perfusing the kidneys, Aortix aims to treat heart failure symptoms by disrupting the cardiorenal syndrome cycle • Potential to offer significant advantages for patients with acute decompensated heart failure (ADHF) who also have worsening renal function

July 30, 2019

Press Releases

Procyrion Raises $30 Million Series D to Support Clinical Trials of its Aortix™ Percutaneous Blood Pump for Treating Heart Failure Patients

Press Release

The $30M Series D funding, led by a new investor, Bluebird Ventures, will support the Aortix's pilot study through the submission of an FDA IDE application for its pivotal trial.

July 9, 2019

Press Releases

Procyrion Named Most Innovative Heart Pump Technology in 2018 Global Healthcare and Pharmaceutical Awards

Press Release

Procyrion awarded the Most Innovative Heart Pump Technology award in the 2018 Global Healthcare and Pharmaceutical Awards for their device, Aortix™, a catheter-deployed circulatory support device designed initially to address cardiorenal syndrome in heart failure patients.

August 23, 2018

Press Releases
Awards

Procyrion Selects Former Abbott/St. Jude Medical Group President Dr. Eric S. Fain as CEO

Press Release

The Board of Directors has chosen Dr. Fain—with > 30 years of experience—to build upon the foundation of innovative technology established over recent years and accelerate the progression of product development leading to human clinical trials and commercialization of the company’s novel and proprietary heart pump.

July 23, 2018

Press Releases

Medical Device Company Procyrion, Inc. Hires Three to Support Growth; Continues to Build Team

Press Release

The company has added five team members in the past sixty days on the heels of closing $16 Million Series C.

July 10, 2018

Press Releases
Press Releases

Procyrion, Inc. Wins Best Overall Medical Device Product in 2018 MedTech Breakthrough Awards

Press Release

Procyrion wins best overall medical device product in 2018 MedTech Breakthrough Awards

July 2, 2018

Awards

Procyrion, Inc. Announces ISO 13485:2016 Certification

Press Release

Procyrion, Inc. received ISO 13485:2016 certification for Medical Device and Quality Management Systems. This certification is a requirement for regulatory purposes and is an international standard that outlines the requirements for a quality management system specific to the medical devices industry.

May 22, 2018

Press Releases

Procyrion, Inc. Appoints Clinical Operations Pro Tara Burt as Associate Director of Clinical Affairs

Press Release

Procyrion, Inc. announced today the appointment of Tara Burt as Associate Director Clinical Affairs. Burt’s knowledge of clinical strategy, trial execution and operations will be a commanding asset to Procyrion as it continues to advance its intra-aortic heart pump for use in NYHA Class III-IVa heart failure patients

April 30, 2018

Press Releases

Procyrion Names Elisabeth Neely Senior Vice President of Clinical and Regulatory Affairs, Formerly with Abbott

Press Release

Procyrion announces the appointment of Elisabeth (Beth) Neely, RAC, as Senior Vice President of Clinical and Regulatory Affairs. Neely brings to Procyrion more than 20 years of experience as a global regulatory affairs leader, having played a key role in the approval of neuromodulation and cardiac devices.

March 21, 2018

Press Releases

Procyrion Raises $16 Million Series C for Clinical Trials of its Breakthrough Aortix™ Heart Pump

Press Release

Device’s unique cardio-renal effects may provide a novel approach for the treatment of Acutely Decompensated Heart Failure (ADHF)

January 30, 2018

Press Releases

Procyrion Wins 2017 People’s Choice Award at the American Heart Association Health Tech Competition

press release

Procyrion Inc. today announced they have won the People’s Choice Award from the American Heart Association’s (AHA) during the 2017 Health Tech Competition with their ground-breaking technology, Aortix™. The competition recognizes innovative healthcare solutions that improve patient outcomes for heart health.

November 13, 2017

Press Releases
Awards

Procyrion, Inc. Chosen to Present at EuroPCR 2017 in Paris

Procyrion

Heart pump developer Procyrion, Inc. has been selected to participate in the 2017 EuroPCR, which will take place May 16th to 19th at the Palais des Congrès in Paris, France. Chief Scientific Officer Jace Heuring will deliver a presentation and discuss Aortix™.

May 9, 2017

Press Releases

Procyrion Continues to Expand Adding Operations Manager

Procyrion

The Houston-based developer of a novel circulatory assist device intended to treat chronic heart failure, Procyrion, Inc., announced today it has added a key team member as it continues its path towards commercialization. James Toll has joined the Procyrion team as Operations Manager.

December 6, 2016

Press Releases

Procyrion, Inc. Chosen to Present at the 2016 Device Therapies for Heart Failure in Paris

Procyrion

Heart pump developer, Procyrion, Inc. has been selected to participate in the 2016 Device Therapies for Heart Failure (D-HF), which will take place December 2 and 3 at the Novotel Paris Centre Tour Eiffel in Paris, France.

December 1, 2016

Press Releases

Procyrion Expands Office Space in Preparation for Commercialization and Growing Team

Bloomberg

Houston heart pump developer Procyrion Inc. today announced the expansion of their office to support their growth and the further development of their ground breaking technology, Aortix™, a catheter-based circulatory support device.

November 4, 2016

Press Releases
Articles

Procyrion Named One Of The “Best Entrepreneurial Companies In America” By Entrepreneur Magazine’s 2016 Entrepreneur 360™ List

Entrepreneur Magazine

Houston heart pump developer Procyrion Inc. today announced they have been recognized as one of the “Best Entrepreneurial Companies in America” by Entrepreneur magazine’s Entrepreneur 360™ List, the most comprehensive analysis of private companies in America.

October 25, 2016

Press Releases

Procyrion Adds Veteran Electrical Engineer to Further Develop Technology

Procyrion

Micro heart pump maker Procyrion has added a key team member as it continues on its path towards commercialization. The Houston-based developer of a novel circulatory assist device intended to treat chronic heart failure announced today that Christian Landry has joined the Procyrion team as Product Development Manager.

October 20, 2016

Press Releases

Procyrion Board of Directors Elects Gary Burbach as Chairman

Procyrion

Procyrion, the Houston-based developer of Aortix™, a percutaneous circulatory assist device intended to treat chronic heart failure (HF) and related conditions, today announced Gary Burbach as the company’s Chairman of the Board of Directors. Burbach previously served as an independent director for Procyrion.

July 13, 2016

Press Releases

Procyrion Wins MD+DI MedTech Startup Showdown Challenge

Procyrion

Houston heart pump developer Procyrion Inc. today announced they have won the Medical Device and Diagnostic Imaging (MD+DI) Magazine’s 2016 MedTech Startup Showdown Challenge with their ground breaking technology, Aortix™, a catheter-based circulatory support device.

May 2, 2016

Press Releases
Awards

Procyrion Appoints New Board Member

Procyrion

Procyrion, the Houston-based developer of a percutaneous circulatory assist device intended to treat chronic heart failure, announced today that Gary Burbach will be joining its board of directors. Burbach currently serves as a director or advisor to multiple private, venture-backed and public life science companies.

March 22, 2016

Press Releases

Procyrion Wins Johnson & Johnson Quick Fire Challenge and Receives Year Residency at the New JLABS @ TMC

Procyrion

Procyrion Inc. today announced they have won the Johnson & Johnson Quick Fire Challenge with their ground breaking technology, Aortix™, a catheter-based circulatory support device. Procyrion has been awarded a year residency in the new JLABS facility located within the Texas Medical Center’s Innovation Institute.

March 3, 2016

Press Releases
Awards

Procyrion Hires Seasoned Product Development Directors

Procyrion

Procyrion adds key team members as it prepares for first-in-human studies. The Houston-based developer of a circulatory assist device intended to treat chronic heart failure announced today that Chris Durst, PhD, is senior director of product development and Ronnie Earles is associate director of product development.

February 10, 2016

Press Releases

Katherine Cox Joins Procyrion as Senior Director of Quality Assurance

Procyrion

Procyrion, Inc., a medical device firm focused on developing a next-generation circulatory support pump for NYHA Class III heart failure patients, today announced that Katherine Cox has been hired as Senior Director of Quality Assuranceto to lead the company’s quality assurance efforts.

December 3, 2015

Press Releases

Houston Medical Developer Earns €30,000 For Circulatory Support Pump In International Life Sciences Competition

Universal Biotech

Procyrion Inc. today earned the 2015 Universal Biotech Innovation Prize for Aortix™, a catheter-based circulatory support device. With the top two most innovative projects, Procyrion and Pixium Vision, will share a grant award and a year of consulting services offered by organizer Universal Biotech, valued at €60,000.

October 5, 2015

Press Releases
Awards

Procyrion Hires Bioengineer Interns Benavides, Songkakul To Advance Development of Micro Heart Pump

Procyrion

Procyrion, Inc., developers of the first catheter-deployed circulatory assist device for the ambulatory treatment of heart failure, appointed bioengineer interns Omar Benavides, Ph.D. to senior product development engineer and Tanner Songkakul to product development engineer.

May 4, 2015

Press Releases

Procyrion Appoints Dr. Manesh Patel of Duke University Medical Center To Scientific Advisory Board

Procyrion

Medical device firm Procyrion, Inc., developing the first catheter-deployed circulatory assist device for the ambulatory treatment of heart failure, announced today that interventional cardiologist Dr. Manesh Patel of Duke University Medical Center has joined the company’s scientific advisory board.

February 16, 2015

Press Releases

$50,000 Grant Progress Update At Annual Pediatric Innovation Expo

Procyrion

Omar Benavides, Ph.D., a senior product development engineer with Procyrion, presented results from the first large animal study completed with the modified circulatory assist device under the grant at the Consortium’s 2nd Annual Pediatric Device Innovation Competition held at the University of Maryland.

February 12, 2015

Press Releases

Procyrion, Inc. To Present Aortix™ Abstract At American Society for Artificial Internal Organs 60th Annual Conference

Procyrion

Following blind peer review, Procyrion Inc.’s abstract, “Aortix™ Percutaneous Circulatory Assist Device Decreases Afterload, Improves Renal Function in Chronic HF,” has been selected for oral presentation at the American Society for Artificial Internal Organs (ASAIO) 60th annual conference...

May 12, 2014

Press Releases

Procyrion, Inc. to Present Circulatory Support Pump at International Society for Heart and Lung Transplantation’s Annual Meeting

Procyrion

Procyrion’s team of life science entrepreneurs have been accepted to present Aortix™, an intra-aortic ambulatory support device for cardiorenal heart failure patients, at the International Society for Heart and Lung Transplantation’s (ISHLT) 34th Annual Meeting & Scientific Session in San Diego April 10 – 13, 2014.

April 1, 2014

Press Releases

Procyrion, Inc. Recognized as “Top Life Science Company” At 2014 Texas Life Science Forum

Procyrion

Houston-based Procyrion, Inc. has been recognized by the Rice Alliance as a “Top Life Science Company” at the 2014 Texas Life Science Forum for its Aortix™, the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure.

February 27, 2014

Press Releases

Procyrion, Inc. Selected to Present Novel Circulatory Support Technology at 2014 Texas Life Science Forum

Procyrion

Houston-based Procyrion, Inc. has been selected to present and discuss future plans for Aortix™, the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure, at the 2014 Texas life Science Forum.

February 18, 2014

Press Releases

Procyrion Announces Formation of Scientific Advisory Board

Procyrion

Procyrion, Inc., a medical device company developing the first catheter-deployed circulatory assist device, announces the appointment of leading cardiologists and cardiovascular researchers Emma Birks, MBBS, PhD; Hani Sabbah, PhD; Keith Aaronson, MD and Joseph Rogers, MD to its newly formed scientific advisory board.

December 31, 2013

Press Releases